Reuters logo
BRIEF-Emergent Tech says Pure MHC, AbbVie to embark on research, license deal
January 9, 2017 / 2:54 PM / a year ago

BRIEF-Emergent Tech says Pure MHC, AbbVie to embark on research, license deal

Jan 9 (Reuters) - Emergent Technologies Inc

* Emergent says Pure MHC, AbbVie will embark on research, license deal to discover peptide targets for use with t-cell receptor therapeutics in cancers Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below